Efficacy, Safety and Immunogenicity Study of Recombinant Human C1 Inhibitor for the Treatment of Acute HAE Attacks
Public ClinicalTrials.gov record NCT01188564. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Randomized, Double-blind, Placebo-controlled Study With an Open-label Extension Evaluating the Efficacy, Safety and Immunogenicity of Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks of Angioedema in Patients With HAE
Study identification
- NCT ID
- NCT01188564
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Pharming Technologies B.V.
- Industry
- Enrollment
- 75 participants
Conditions and interventions
Conditions
Interventions
- rhC1INH Drug
- Placebo (Saline) Drug
Drug
Eligibility (public fields only)
- Age range
- 13 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2010
- Primary completion
- Nov 30, 2012
- Completion
- Feb 28, 2013
- Last update posted
- Aug 6, 2015
2011 – 2013
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Allergy, Asthma & Immunology, Assoc, Ltd. | Scottsdale | Arizona | 85251 | — |
| Allergy and Asthma Institute of the Valley | Granada Hills | California | 91344 | — |
| UCLA Department of Medicine Division of Clinical Immunology, David Geffen School of Medicine | Los Angeles | California | 90095 | — |
| USF Asthma, Allergy and Immunology Clinical Research Unit | Tampa | Florida | 33613 | — |
| Family Allergy and Asthma Center | Atlanta | Georgia | 30342 | — |
| Institute for Asthma and Allergy, P.C. | Chevy Chase | Maryland | 20815 | — |
| Asthma & Allergy Center - Washington University School of Medicine | St Louis | Missouri | 63141 | — |
| University of Cincinnati Physicians, Inc. | Cincinnati | Ohio | 45267 | — |
| Optimed Research, LTD | Columbus | Ohio | 43235 | — |
| Baker Allergy, Asthma and Dermatology Research Center, LLC | Lake Oswego | Oregon | 97035 | — |
| Pennsylvania State- Milton S. Hershey Medical Center | Hershey | Pennsylvania | 17033 | — |
| AARA Research Center | Dallas | Texas | 75231 | — |
| University of Texas - Medical Branch | Galveston | Texas | 77555 | — |
| Allergy, Asthma & Immunology Clinic, P.A. | Irving | Texas | 75063 | — |
| Marycliff Allergy Specialists | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01188564, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 6, 2015 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01188564 live on ClinicalTrials.gov.